期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺原位癌研究的新进展 被引量：7

原文传递
导出
摘要 乳腺原位癌一直是肿瘤病理学领域的研究热点。虽然关于乳腺原位癌的研究报告已经有很多，但是近年来一些新的进展很值得关注，例如：乳腺导管内癌（DCIS）的分子亚型、细胞遗传学、进展途径、临床诊断和治疗等方面的研究；乳腺小叶原位癌（LCIS）的克隆性、染色体变化及变异类型的研究；以及DCIS和LCIS关系的研究等。在此综述如下。
作者 王淑玲 牛昀
机构地区 天津医科大学附属肿瘤医院乳腺病理研究室乳腺癌防治教育部重点实验室天津市肿瘤防治重点实验室
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第8期570-573,共4页 National Medical Journal of China
基金 国家自然科学基金资助项目（30872519） 天津市自然科学基金（09JCYBJC10100） 教育部长江学者和创新团队计划（TRT0743）
关键词 乳腺原位癌 乳腺小叶原位癌 乳腺导管内癌 肿瘤病理学 细胞遗传学 染色体变化 分子亚型 临床诊断
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献32

  • 1O'Flynn EA,Morel JC,Gonzalez J,et al.Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy.Oin Radiol,2009,64:178-183.
  • 2Meijnen P,Peterse JL,Antonini N,et al.Immunohistochemicalcategorisation of ductal carcinoma in situ of the breast.British J Cancer,2008,98:137-142.
  • 3Bryan BB,Schnitt SJ,Collins LC,et al.Ductal carcinomain situ with besal-iike phenotype,a possible precursor to invasive basallike breast cancer.Mod Pathol,2006,19:617-621.
  • 4Steinman S,Wang J,Bourne P,et al.Expression of cytokeratin markers,ER-alpha,PR,HER-2/neu,and EGFR in pure ductal carcinoma in aim(DCIS)and DCIS with co-existing invesive ductal carcinoma(IDC)ofthe breast.Ann Clin Lab Sci,2007,37:127-134.
  • 5陈健,张旭,田茹,郭瑞峰,梁化印,董红梅.乳腺导管内癌分子分型应用研究[J].临床与实验病理学杂志,2009,25(1):29-32. 被引量：10
  • 6Tsikitis VL,Chung MA.Biology of ductal carcinoma in situ classification based on biologic potential.Am J Clln Oncol,2006,29:305-310.
  • 7Tavaesoli FA,Eusebi V.AFIP Atlas of tumor pathology.series 4 (Tumors of the mammary gland).Washington,DC:American Registry of Pathology and Armed Force Institute of Pathology,2009:54-71.
  • 8Gao Y,Niu Y,Wang X,et al.Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.J Mol Med,2009,87:145-152.
  • 9Alexe G,Dalgin GS,Scanfeld D,et al.Breast cancer stratification from analysis of micro-array data of micro-dissected specimens.Genome Inform,2007,18:130-140.
  • 10Daigin GS,Alexe G,Scanfeld D,et al.Portraits of brenst cancer progression.BMC Bioinformatics,2007,8:291.

二级参考文献17

  • 1Perou C M, Serlie T, Eisen M B, et al. Molecular portraits of human breast turnouts[ J ]. Nature ,2000,406 ( 6797 ) :747 - 752.
  • 2Rakha E A, EI-Sayed M E, Green A R,et al. Breast carcinoma with basal differentiation : a proposal for pathology definition based on basal cytokeratin expression[ J]. Histopathology,2007,50(4) :434 -438.
  • 3Sorlie T, Perou C M, Tibshirani R. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J]. Proc Natl Acad Sci USA, 2001,98 (19):10869 - 10874.
  • 4Livasy C A, Karaea G, Nanda R,et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma [ J ]. Mod Pathol, 2006,19(2) :264 -271.
  • 5Fulford L G,Easton D F,Reis-Filho J S,et al. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast [ J ]. Histopathology,2006,49 ( 1 ) : 22 -34.
  • 6Dabbs D J,Chivukula M ,Carter G,et al. Basal phenotype of ductal carcinoma in situ : recognition and immunohistologic profile [ J ]. Mod Pathol,2006,19( 11 ) :1506 - 1511.
  • 7Bryan B B,Schnitt S J,Collins C L. Ductal carcinoma in situ with basal-like pbenotype: a possible precursor to invasive basal-like breast cancer [ J ]. Mod Pathol,2006,19 ( 5 ) : 617 - 621.
  • 8Livasy C A, Perou C M, Karaca G, et al. Identification of a basallike subtype of breast ductal carcinoma in situ [ J ]. Hum Pathol, 2007,38 ( 2 ) : 197 - 204.
  • 9Carey L A, Perou C M, Livasy C A,et al. Race, breast cancer subtypes and survival in the Carolina breast cancer study[ J ]. JAMA, 2006,295 ( 21 ) :2492 - 2502.
  • 10Li H, Cherukuri P, Li N, et al. Nestin is expressed in the basal/ myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors [ J ]. Cancer Res, 2007,67 ( 2 ) : 501 -510.

共引文献9

同被引文献65

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量：1368
  • 2韦佳明,刘治滨.乳腺导管内癌的腋窝淋巴结转移率与术式选择[J].中国癌症杂志,2004,14(5):472-473. 被引量：5
  • 3Mokbel K. Current management of ductaI carcinoma in situ of the breast[J]. Int J Clin Oneol, 200a, 8 (1) .- 18-22.
  • 4Mossa-Basha M, Fundaro GM, Shah BA, et al. Ductal carcinoma in situ of the breast:MR imaging findings with histopathologlc cor- relation[J]. Radiographics, 2010,30(6) : 1673-1687.
  • 5Jansen SA,Newstead GM, Abe H,et al. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammanographic MR appearance and nuclear grade[J]. Radiolo- gy,2007,245(3) :684- 691.
  • 6任国胜,厉红元,BrettesJ.乳腺小叶原位癌:当前的概念和争论(附145例分析报告)[J].内分泌外科,2006,5(4):9-12.
  • 7Menell JI-I, Morris EA, Dershaw DD, et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammog- raphy and magnetic resonance imaging[J] Breast J, 2005,11 (6): 382-390.
  • 8Bazzocchi M, Zuiani C, Panizza P, et al. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammogra- phy: results of a multicenter trail [J]. AJR, 2006,186 ( 6 ) :1723- 1732.
  • 9Ouidi AJ,Schnitt SJ, Fischer L, et al. Vascular permeability fac- tor (vascular endothelial growth factor) expression and anglo- genesis in patients with ductal carcinoma in situ of the breast[J]. Cancer, 1997,80(10) : 1945-1953.
  • 10Jansen SA, Paunesku T, Fan X, et al. Ductal carcinoma in situX ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplasticmammary ducts in a murine model[J]. Radiology, 2009,253 (2) : 399-406.

引证文献7

二级引证文献34

中华医学杂志
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部